Epstein Secrets

urchase - and Matrix's sale - continues the intrigue on Xero's shareholder register. Earlier thLs month the powerful Silicon Valley billionaire and Donald Trump adviser Peter Thiel sold shares worth about 323 million in the company. taking his stake below the 5 per cent threshold at which it must be publicly

e powerful Silicon Valley billionaire and Donald Trump adviser Peter Thiel sold shares worth about 323 m

onth the powerful Silicon Valley billionaire and Donald Trump adviser Peter Thiel sold shares worth about

rom firms actively investing in this region include Accel Partners (an Investor in Xero and Campaign Monitor. and an early backer of Atlassian) and Index Ventures (an investor in SafetyCulture and Culture Amp). Xero's ASX listing Ls up about 10 per cent this year. outpacing a 3 per cent rLse for the broader

rowitz's loan in question went to a portfolio company for which it's the beneficial owner. The list also included: Companies with ties to President Trump, more than 88,000 loans for religious organizations, a number of investment firms and some nonprofit groups that advocate against such massive gov

. The list also included: Companies with ties to President Trump, more than 88,000 loans for religious organizati

ow A handful of venture capital firms said they didn't seek bailouts or get money even though yesterday's list of PPP recipients showed otherwise. Index Ventures and Foundation Capital, both listed as having been approved for more than $1 million, are among those saying they never applied for funding. Andree

L. Bettermann Erik Behermann Jeffrey L. Bewkes Donald S. Beyer Homi K. Bhabha Neeraj Bharadwaj Hari

onomic and Political News Handelsblatt Germany Donald J. Gogel President and Chief Executive Officer Cla

Officer Deputy Chairman Executive Vice-President, General Counsel and Corporate Secretary Yahoo! Sad Catalyst Private Equity - Cleantech Fund Index Ventures II Sole 24 Ore New England Aquarium Switzerland Jordan Switzerland Italy USA The British Land Company Plc United Kingdom Merck & Co. Inc. J